미시간의 크론병 임상 시험
크론병 관련 연구 17개가 미시간 내 여러 지역에서 참여자를 모집하고 있습니다.
미시간의 도시
공식 연구 텍스트(영어)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287), Ypsilanti
피험자 모집 중3상
전 연령 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Michigan ( Site 5060), Ann Arbor
- Clinical Research Institute of Michigan, LLC ( Site 5002), Clinton Township
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06430801A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07483099A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Michigan Center of Medical Research, Farmington Hills
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07499232A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Investigational Site Number: 8400008, Wyoming
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06958536A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
- Huron Gastro, Ypsilanti
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- West Michigan Clinical Research Center /ID# 280480, Wyoming
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07697456An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Henry Ford Medical Center - Columbus-Site Number: 8400118, Novi
- Gastroenterology Associates of Western Michigan-Site Number: 8400060, Wyoming
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07184931A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Hospital of Michigan, Detroit
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06405087Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Henry Ford Medical Center - Columbus /ID# 266503, Novi
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06548542A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital of Michigan, Detroit
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06100289Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- University of Micigan, Ann Arbor
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT07456566Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Henry Ford Columbus Center, Detroit
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 4. 27. 업데이트됨 · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Ypsilanti
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT07113522A Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's Disease
- University of Michigan, Ann Arbor
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 1. 15. 업데이트됨 · NCT05849012Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Michigan, Ann Arbor
피험자 모집 중1/2상
18세 ~ 65세 · 모든 성별 · 2025. 12. 10. 업데이트됨 · NCT06721962ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.